PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22297387-7	2012	Efavirenz (single dose) slightly increased ezetimibe absorption and markedly decreased exposure to ezetimibe-glucuronide (single dose and multiple dose), which may be explained by inhibition of UGT1A1 and ABCB1 (in vitro data).	efavirenz	0-9	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	194-200	
34093191-3	2021	UGT1A1*28 and CYP2B6 c.516G>T have been proposed to be related with higher toxicity by ATV and EFV, respectively.	efavirenz	95-98	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	0-6	
32829410-5	2021	Associations were characterized with CYP2B6 and UGT1A1 genotypes that affect efavirenz and INSTI metabolism, respectively.	efavirenz	77-86	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	48-54	
22252501-6	2012	Efavirenz also moderately inhibited UGT1A1-mediated 17beta-estradiol 3-glucuronidation, with a K(i) value of 40.3 muM, but did not inhibit UGT1A6-mediated 1-naphthol glucuronidation.	efavirenz	0-9	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	36-42